Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allmicroalgae is a leading European biotechnology company specializing in the production and commercialization of high-quality microalgae-based solutions for the food, nutraceutical, cosmetic, and feed industries. Based in Portugal, the company utilizes advanced cultivation technologies, including large-scale tubular photobioreactors and fermentation systems, to produce a diverse range of species such as Chlorella vulgaris, Spirulina, and Nannochloropsis. Their portfolio includes organic-certified biomass, powders, and extracts rich in proteins, omega-3 fatty acids (EPA), and antioxidants. As a subsidiary of the Greentech Group, Allmicroalgae provides both standardized ingredients and customized contract manufacturing services tailored to specific client requirements. The company is recognized for its commitment to sustainability and holds rigorous certifications, including EU Organic, GMP, and ISO 22000.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allmicroalgae.